Ino Y - Search Results

1

Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray.

Murakoshi Y, Honda K, Sasazuki S, Ono M, Negishi A, Matsubara J, Sakuma T, Kuwabara H, Nakamori S, Sata N, Nagai H, Ioka T, Okusaka T, Kosuge T, Shimahara M, Yasunami Y, Ino Y, Tsuchida A, Aoki T, Tsugane S, Yamada T. Murakoshi Y, et al. Among authors: ino y. Cancer Sci. 2011 Mar;102(3):630-8. doi: 10.1111/j.1349-7006.2010.01818.x. Epub 2010 Dec 28. Cancer Sci. 2011. PMID: 21199170 Free article.

2

E-cadherin regulates the association between beta-catenin and actinin-4.

Hayashida Y, Honda K, Idogawa M, Ino Y, Ono M, Tsuchida A, Aoki T, Hirohashi S, Yamada T. Hayashida Y, et al. Among authors: ino y. Cancer Res. 2005 Oct 1;65(19):8836-45. doi: 10.1158/0008-5472.CAN-05-0718. Cancer Res. 2005. PMID: 16204054

3

Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer.

Honda K, Yamada T, Hayashida Y, Idogawa M, Sato S, Hasegawa F, Ino Y, Ono M, Hirohashi S. Honda K, et al. Among authors: ino y. Gastroenterology. 2005 Jan;128(1):51-62. doi: 10.1053/j.gastro.2004.10.004. Gastroenterology. 2005. PMID: 15633123

4

Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.

Nitori N, Ino Y, Nakanishi Y, Yamada T, Honda K, Yanagihara K, Kosuge T, Kanai Y, Kitajima M, Hirohashi S. Nitori N, et al. Among authors: ino y. Clin Cancer Res. 2005 Apr 1;11(7):2531-9. doi: 10.1158/1078-0432.CCR-04-0866. Clin Cancer Res. 2005. PMID: 15814630

5

Clinical significance of tumor-infiltrating immune cells focusing on BTLA and Cbl-b in patients with gallbladder cancer.

Oguro S, Ino Y, Shimada K, Hatanaka Y, Matsuno Y, Esaki M, Nara S, Kishi Y, Kosuge T, Hiraoka N. Oguro S, et al. Among authors: ino y. Cancer Sci. 2015 Dec;106(12):1750-60. doi: 10.1111/cas.12825. Epub 2015 Oct 22. Cancer Sci. 2015. PMID: 26395180 Free PMC article.

6

Alternative splice variant of actinin-4 in small cell lung cancer.

Honda K, Yamada T, Seike M, Hayashida Y, Idogawa M, Kondo T, Ino Y, Hirohashi S. Honda K, et al. Among authors: ino y. Oncogene. 2004 Jul 1;23(30):5257-62. doi: 10.1038/sj.onc.1207652. Oncogene. 2004. PMID: 15122314

7

Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.

Shimamura T, Sakamoto M, Ino Y, Shimada K, Kosuge T, Sato Y, Tanaka K, Sekihara H, Hirohashi S. Shimamura T, et al. Among authors: ino y. Clin Cancer Res. 2002 Aug;8(8):2570-5. Clin Cancer Res. 2002. PMID: 12171885

8

Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice.

Yamada T, Mori Y, Hayashi R, Takada M, Ino Y, Naishiro Y, Kondo T, Hirohashi S. Yamada T, et al. Among authors: ino y. Cancer Res. 2003 Mar 1;63(5):895-901. Cancer Res. 2003. PMID: 12615699

9

Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression.

Shimamura T, Sakamoto M, Ino Y, Sato Y, Shimada K, Kosuge T, Sekihara H, Hirohashi S. Shimamura T, et al. Among authors: ino y. J Clin Oncol. 2003 Feb 15;21(4):659-67. doi: 10.1200/JCO.2003.06.179. J Clin Oncol. 2003. PMID: 12586803

10

Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer.

Ino Y, Yamazaki-Itoh R, Oguro S, Shimada K, Kosuge T, Zavada J, Kanai Y, Hiraoka N. Ino Y, et al. PLoS One. 2013;8(2):e55146. doi: 10.1371/journal.pone.0055146. Epub 2013 Feb 12. PLoS One. 2013. PMID: 23424623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

451 results

Search Page